Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AMG-305 by Amgen for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
AMG-305 is under clinical development by Amgen and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....
AMG-305 by Amgen for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
AMG-305 is under clinical development by Amgen and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
AMG-305 by Amgen for Epithelial Ovarian Cancer: Likelihood of Approval
AMG-305 is under clinical development by Amgen and currently in Phase I for Epithelial Ovarian Cancer. According to GlobalData, Phase...